FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

GENEREX BIOTECHNOLOGY CORP: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2019-08-01 – 2020-01-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/0850adb7-1148-46ee-9d2f-7d42061df157

Reported value

$4.546M{"amount": 4546014, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
GENEREX BIOTECHNOLOGY CORP
Metric
cashflow_financing
Period
2019-08-01 – 2020-01-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001607062-20-000067 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T10:26:37.356960+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001059784/cashflow-financing/2020-01-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.